LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Akcijų sąrašas・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

23.4 2.32

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

23.4

Max

23.4

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-10M -67M
Pelno marža	-7,753.425
Darbuotojai	186
EBITDA	-9.8M -73M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+91.14% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-25

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	23M 1.5B
Ankstesnė atidarymo kaina	21.08
Ankstesnė uždarymo kaina	23.4

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

18.91 / 20.63 Palaikymas ir pasipriešinimas

Celldex Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-20 17:37; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

2026-02-21 14:31; UTC

Įsigijimai, susijungimai, perėmimai

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

2026-02-21 05:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-02-20 23:12; UTC

Įsigijimai, susijungimai, perėmimai

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

2026-02-20 22:12; UTC

Uždarbis

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

2026-02-20 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-20 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-02-20 21:23; UTC

Uždarbis

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

2026-02-20 21:20; UTC

Rinkos pokalbiai

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

2026-02-20 21:01; UTC

Įsigijimai, susijungimai, perėmimai

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

2026-02-20 20:38; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

2026-02-20 20:17; UTC

Rinkos pokalbiai

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

2026-02-20 20:11; UTC

Rinkos pokalbiai

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

2026-02-20 19:59; UTC

Rinkos pokalbiai

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

2026-02-20 19:58; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

2026-02-20 19:49; UTC

Rinkos pokalbiai

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

2026-02-20 19:09; UTC

Rinkos pokalbiai

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

2026-02-20 19:00; UTC

Rinkos pokalbiai

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

2026-02-20 18:28; UTC

Rinkos pokalbiai

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

2026-02-20 18:20; UTC

Rinkos pokalbiai

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

2026-02-20 18:05; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-02-20 18:04; UTC

Rinkos pokalbiai

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

2026-02-20 17:38; UTC

Rinkos pokalbiai

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

2026-02-20 17:24; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-20 17:24; UTC

Rinkos pokalbiai

Correction to Treasury Yields Fall Market Talk

2026-02-20 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-20 16:53; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-02-20 16:53; UTC

Rinkos pokalbiai

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

2026-02-20 16:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-20 16:45; UTC

Rinkos pokalbiai

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

Akcijų palyginimas

Kainos pokytis

Celldex Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

91.14% į viršų

12 mėnesių prognozė

Vidutinis 44 USD 91.14%

Aukščiausias 62 USD

Žemiausias 24 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Celldex Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

4 ratings

Pirkti

Laikyti

Parduoti

Remiantis 4 analitikų, pateikusių Celldex Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

18.91 / 20.63Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.